These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32543766)

  • 1. The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: Insights to inform clinical decision-making from a fine-needle aspiration sample.
    Krane JF; Cibas ES; Endo M; Marqusee E; Hu MI; Nasr CE; Waguespack SG; Wirth LJ; Kloos RT
    Cancer Cytopathol; 2020 Jul; 128(7):452-459. PubMed ID: 32543766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid nodule molecular profiling: The clinical utility of Afirma Xpression Atlas for nodules with Afirma Genomic Sequencing Classifier-suspicious results.
    Babazadeh NT; Sinclair TJ; Krishnamurthy V; Jin J; Heiden KB; Shin J; Berber E; Siperstein A
    Surgery; 2022 Jan; 171(1):155-159. PubMed ID: 34924179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Getting more out of molecular testing for indeterminate thyroid nodules.
    Angell TE
    Cancer Cytopathol; 2019 Sep; 127(9):555-556. PubMed ID: 31237737
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the performance of the Afirma gene expression classifier.
    Hang JF; Westra WH; Cooper DS; Ali SZ
    Cancer Cytopathol; 2017 Sep; 125(9):683-691. PubMed ID: 28544601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single Institution Experience with Afirma and Thyroseq Testing in Indeterminate Thyroid Nodules.
    Gortakowski M; Feghali K; Osakwe I
    Thyroid; 2021 Sep; 31(9):1376-1382. PubMed ID: 33764195
    [No Abstract]   [Full Text] [Related]  

  • 6. Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier.
    Wong KS; Angell TE; Strickland KC; Alexander EK; Cibas ES; Krane JF; Barletta JA
    Thyroid; 2016 Jul; 26(7):911-5. PubMed ID: 27219469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between Sonographic Characteristics and Afirma Gene Expression Classifier Results in Thyroid Nodules With Indeterminate Fine-Needle Aspiration Cytopathology.
    Zhu QL; Faquin WC; Samir AE
    AJR Am J Roentgenol; 2015 Oct; 205(4):861-5. PubMed ID: 26397337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experience.
    Lastra RR; Pramick MR; Crammer CJ; LiVolsi VA; Baloch ZW
    Cancer Cytopathol; 2014 Oct; 122(10):737-44. PubMed ID: 25123499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making.
    Ferris RL; Baloch Z; Bernet V; Chen A; Fahey TJ; Ganly I; Hodak SP; Kebebew E; Patel KN; Shaha A; Steward DL; Tufano RP; Wiseman SM; Carty SE;
    Thyroid; 2015 Jul; 25(7):760-8. PubMed ID: 26058403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extending expressed RNA genomics from surgical decision making for cytologically indeterminate thyroid nodules to targeting therapies for metastatic thyroid cancer.
    Ali SZ; Siperstein A; Sadow PM; Golding AC; Kennedy GC; Kloos RT; Ladenson PW
    Cancer Cytopathol; 2019 Jun; 127(6):362-369. PubMed ID: 31017745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy.
    Sacks WL; Bose S; Zumsteg ZS; Wong R; Shiao SL; Braunstein GD; Ho AS
    Cancer Cytopathol; 2016 Oct; 124(10):722-728. PubMed ID: 27347838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes of Thyroid Nodule AFIRMA GEC Testing and Literature Review: An Institutional Experience.
    Vora A; Holt S; Haque W; Lingvay I
    Otolaryngol Head Neck Surg; 2020 May; 162(5):634-640. PubMed ID: 32182188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
    Jara SM; Bhatnagar R; Guan H; Gocke CD; Ali SZ; Tufano RP
    Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules.
    Hu MI; Waguespack SG; Dosiou C; Ladenson PW; Livhits MJ; Wirth LJ; Sadow PM; Krane JF; Stack BC; Zafereo ME; Ali SZ; Weitzman SP; Hao Y; Babiarz JE; Kennedy GC; Kloos RT
    J Clin Endocrinol Metab; 2021 Jul; 106(8):2198-2207. PubMed ID: 34009369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of molecular markers in pre-operative assessment of thyroid nodules.
    Bhatia P; Abd Elmageed ZY; Friedlander P; Aslam R; Kandil E
    Future Oncol; 2015; 11(16):2343-50. PubMed ID: 26260812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Rapidly Growing Thyroid Nodule: A Diagnostic Challenge in Fine Needle Aspiration.
    Thodou E; Sarantopoulou C; Psachoulia C; Ravazoula P; Armoni A; Schmitt FC
    Acta Cytol; 2020; 64(4):390-393. PubMed ID: 31597130
    [No Abstract]   [Full Text] [Related]  

  • 17. GLIS rearrangements in thyroid nodules: A key to preoperative diagnosis of hyalinizing trabecular tumor.
    Nikiforova MN; Nikiforov YE; Ohori NP
    Cancer Cytopathol; 2019 Sep; 127(9):560-566. PubMed ID: 31373774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the Afirma Gene Expression Classifier Result on the Surgical Management of Thyroid Nodules with Category III/IV Cytology and Its Correlation with Surgical Outcome.
    Chaudhary S; Hou Y; Shen R; Hooda S; Li Z
    Acta Cytol; 2016; 60(3):205-10. PubMed ID: 27344463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes.
    Baca SC; Wong KS; Strickland KC; Heller HT; Kim MI; Barletta JA; Cibas ES; Krane JF; Marqusee E; Angell TE
    Cancer Cytopathol; 2017 May; 125(5):313-322. PubMed ID: 28152275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Ancillary Techniques in Thyroid Cytology Specimens.
    Nishino M; Krane JF
    Acta Cytol; 2020; 64(1-2):40-51. PubMed ID: 30947167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.